Market Cap ₹21 Cr.
Stock P/E
P/B 2.6
Current Price ₹26.7
Book Value ₹ 10.3
Face Value 10
52W High ₹29
Dividend Yield 0%
52W Low ₹ 7.3
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) |
---|
Net Sales |
Other Income |
Total Income |
Total Expenditure |
Operating Profit |
Interest |
Depreciation |
Exceptional Income / Expenses |
Profit Before Tax |
Provision for Tax |
Profit After Tax |
Adjustments |
Profit After Adjustments |
Adjusted Earnings Per Share |
#(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|
Net Sales | 15 | 24 | 16 | 4 | 13 | 4 | 2 | |
Other Income | 0 | 0 | 0 | 0 | 0 | 1 | 2 | |
Total Income | 16 | 24 | 16 | 4 | 13 | 5 | 4 | |
Total Expenditure | 13 | 22 | 16 | 4 | 15 | 4 | 4 | |
Operating Profit | 2 | 2 | 0 | 0 | -2 | 1 | 0 | |
Interest | 1 | 1 | 2 | 1 | 0 | 1 | 1 | |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Profit Before Tax | 1 | 1 | -2 | -1 | -2 | -1 | -1 | |
Provision for Tax | 0 | 0 | -0 | -0 | -1 | -0 | -0 | |
Profit After Tax | 1 | 0 | -1 | -1 | -2 | -0 | -1 | |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Profit After Adjustments | 1 | 0 | -1 | -1 | -2 | -0 | -1 | |
Adjusted Earnings Per Share | 1.1 | 0.5 | -1.7 | -1.5 | -2.3 | -0.6 | -1.1 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | -50% | -21% | -39% | 0% |
Operating Profit CAGR | -100% | 0% | -100% | 0% |
PAT CAGR | 0% | 0% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 184% | 53% | 25% | NA% |
ROE Average | -11% | -12% | -12% | -7% |
ROCE Average | -0% | -2% | -1% | 2% |
#(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|
Shareholder's Funds | 11 | 11 | 10 | 9 | 7 | 7 | 8 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 7 | 8 | 8 | 7 | 11 | 2 | 2 |
Other Non-Current Liabilities | 0 | 0 | -0 | -1 | -1 | -1 | -1 |
Total Current Liabilities | 34 | 24 | 15 | 16 | 13 | 13 | 12 |
Total Liabilities | 52 | 44 | 33 | 32 | 30 | 21 | 21 |
Fixed Assets | 3 | 3 | 3 | 3 | 3 | 2 | 2 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Current Assets | 49 | 40 | 30 | 29 | 27 | 19 | 18 |
Total Assets | 52 | 44 | 33 | 32 | 30 | 21 | 21 |
#(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
Cash Flow from Operating Activities | -4 | 3 | -1 | 1 | -4 | -1 | -0 |
Cash Flow from Investing Activities | -2 | -3 | -0 | 0 | 1 | 0 | -0 |
Cash Flow from Financing Activities | 6 | 2 | -0 | -1 | 4 | 1 | -0 |
Net Cash Inflow / Outflow | -0 | 2 | -1 | -0 | 0 | 0 | -0 |
Closing Cash & Cash Equivalent | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
# | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 1.05 | 0.53 | -1.67 | -1.52 | -2.27 | -0.56 | -1.08 |
CEPS(Rs) | 1.16 | 0.7 | -1.39 | -1.28 | -2.06 | -0.41 | -0.94 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 15.51 | 16.04 | 14.37 | 12.86 | 10.59 | 10.03 | 10.3 |
Core EBITDA Margin(%) | 14.84 | 8.19 | 0.35 | -5.25 | -16.87 | -16.93 | -64.24 |
EBIT Margin(%) | 14.77 | 7.97 | 0.09 | -3.1 | -16.36 | 19.88 | -0.93 |
Pre Tax Margin(%) | 6.96 | 2.08 | -9.32 | -36.19 | -16.72 | -16.58 | -49.99 |
PAT Margin (%) | 4.79 | 1.52 | -7.19 | -27.34 | -12.67 | -11.16 | -37.77 |
Cash Profit Margin (%) | 5.3 | 2.02 | -5.97 | -23.12 | -11.51 | -8.14 | -33.07 |
ROA(%) | 1.42 | 0.77 | -3.05 | -3.29 | -5.19 | -1.55 | -3.99 |
ROE(%) | 6.77 | 3.33 | -10.97 | -11.14 | -19.34 | -5.45 | -11.12 |
ROCE(%) | 10.05 | 8.27 | 0.07 | -0.57 | -9.16 | 3.17 | -0.11 |
Receivable days | 153.75 | 73.3 | 67.86 | 250.14 | 78.76 | 193.94 | 94.75 |
Inventory Days | 931.18 | 538.58 | 636.5 | 2284.68 | 587.88 | 1621.39 | 2556.92 |
Payable days | -514.38 | 110.42 | 71.71 | -2137.81 | 28 | 125.8 | 108.34 |
PER(x) | 18.08 | 29.69 | 0 | 0 | 0 | 0 | 0 |
Price/Book(x) | 1.22 | 0.97 | 0.6 | 0 | 0 | 1.33 | 0.92 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 1.63 | 0.91 | 1.07 | 4.65 | 1.93 | 6.13 | 8.34 |
EV/Core EBITDA(x) | 10.64 | 10.74 | 81.91 | 414.99 | -12.67 | 26.75 | 220.98 |
Net Sales Growth(%) | 0 | 58.03 | -33.08 | -76.1 | 222.83 | -71.89 | -37.57 |
EBIT Growth(%) | 0 | -14.68 | -99.23 | -903.31 | -1603.95 | 134.15 | -102.92 |
PAT Growth(%) | 0 | -49.99 | -417.53 | 9.11 | -49.54 | 75.24 | -111.37 |
EPS Growth(%) | 0 | -49.99 | -417.53 | 9.11 | -49.54 | 75.24 | -92.25 |
Debt/Equity(x) | 1.08 | 1.16 | 1.17 | 1.23 | 2.33 | 1.79 | 1.4 |
Current Ratio(x) | 1.44 | 1.66 | 1.93 | 1.75 | 2.17 | 1.46 | 1.54 |
Quick Ratio(x) | 0.29 | 0.32 | 0.35 | 0.25 | 0.89 | 0.25 | 0.2 |
Interest Cover(x) | 1.89 | 1.35 | 0.01 | -0.09 | -46.17 | 0.55 | -0.02 |
Total Debt/Mcap(x) | 0.88 | 1.19 | 1.95 | 0 | 0 | 1.35 | 1.52 |
# | Mar 2019 | Sep 2019 | Mar 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 72.98 | 72.98 | 73.15 | 73.58 | 73.58 | 73.58 | 66.93 | 66.93 | 66.93 | 66.93 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 27.02 | 27.02 | 26.85 | 26.42 | 26.42 | 26.42 | 33.07 | 33.07 | 33.07 | 33.07 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Mar 2019 | Sep 2019 | Mar 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 0.51 | 0.51 | 0.52 | 0.52 | 0.52 | 0.52 | 0.52 | 0.52 | 0.52 | 0.52 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.26 | 0.26 | 0.26 | 0.26 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.77 | 0.77 | 0.77 | 0.77 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About